A community-based study of the epidemiology of Helicobacter pylori infection and associated asymptomatic gastroduodenal pathology

European Journal of Gastroenterology and Hepatology

Volumn 10, Issue 5, 1998, Pages 375-379

  Buckley, Martin J M ^a   O'Shea, Jacinta ^a   Grace, Antoinette ^b   English, Liam ^c   Keane, Conor ^c   Hourihan, Dermot ^b   O'Morain, Colm A ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Asymptomatic; Community study; Epidemiology; H. pylori

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGE; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DYSPEPSIA; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; SCREENING; SEROPREVALENCE; SOCIAL CLASS; STOMACH MUCOSA;

EID: 0031746374     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199805000-00004     Document Type: Article

References (38)

1. Kuipers EJ, Thijs JC, Festen HPM. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995; 9(Suppl 2):59-70.
2. Coghlan JG, Humphries H, Dooley C, et al. Campylobacter pylori and recurrence of duodenal ulcers - a 12 month follow-up study. Lancet 1987; ii:109-111.
3. Graham DY, Hepps KS, Ramirez FC, Lew GM, Saled J. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993; 28:939-942.
4. O'Morain CA, Buckley M. H. pylori in asymptomatic people. In: Helicobacter pylori. Basic Mechanisms to Clinical Cure. Hunt RH, Tytgat GNJ (editors). Dordrecht, Boston, London: Kluwer Academic Publishers; 1994. pp. 413-420.
5. Vaira D, Miglioli M, Mule P, et al. Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut 1994; 35:309-312.
6. Gasbarrini G, Pretolani S, Bonvicini F, Gatto Mr, Tonelli E, Megraud F. et al. A population based study of Helicobacter pylori infection in a European country: the San Marino Study. Relations with gastrointestinal diseases. Gut 1995; 36:838-844.
7. Scanlon C, Buckley M, McGurgan P, Morrison C, Montague S, O'Morain C. A validated symptom score for dyspepsia. Gastroenterology 1995; 108:A212.
8. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Apt 1995; 9(Suppl 2):33-39.
9. Dooley CP, Cohen H, Fitzgibbons PL, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321:1562-1566.
10. Kosunen TU, Höö K, Rautelin HI, Myllylä G. Age-dependent increase in Campylobacter pylori antibodies in blood donors. Scand J Gastroenterol 1989; 24:110-114.
11. Whitaker CJ, Dubiel AJ, Galpin OP. Social and geographic risk factors in Helicobacter pylori. Epidemiol Infect 1993; 111:63-70.
12. Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9(Suppl 2):45-51.
13. Kuipers EJ, Pena AS, van Kamp G, et al. Seroconversion for Helicobacter pylori. Lancet 1993; 342:328-331.
14. Cullen DJE, Collins BJ, Christiansen KJ, et al. When is Helicobacter pylori infection acquired? Gut 1993; 34:1681-1682.
15. Parsonnet J, Blaser MJ, Perez-Perez GI, Hatgrett-Bean N, Tauxe RV. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992; 102:41-46.
16. Dummer S, Perez-Perez GI, Breining MK, Lee A, Griffith BP. Seroepidemiology of Helicobacter pylori infection in heart transplant recipients. (Abstract) Gastroenterology 1992; 104:A73.
17. Veldhuyzen van Zanten SJO, Pollak PT, Best LM, Bezanson GS, Marrie T. Increasing prevalence of Helicobacter pylori infection with age: continuous risk of infection in adults rather than cohort effect. J Infect Dis 1994; 169:434-437.
18. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986; 8:1-27.
19. Coggon D, Acheson ED. The geography of cancer of the stomach. Br Med Bull 1984; 40:335-341.
20. Sipponen P, Järvi O, Kekki M, Siurala M. Decreased incidence of intestinal and diffuse types of gastric carcinoma in Finland during a 20-year period. Scand J Gastroenterol 1987; 22:865-871.
21. Sipponen P, Seppälä K. Long-term consequences of H. pylori infection: time trends in H. pylori gastritis, gastric cancer and peptic ulcer disease. In Helicobacter pylori. Basic Mechanisms to Clinical Cure. Hunt RH, Tytgat GNJ (editors). Dordrecht, Boston, London: Kluwer Academic Publishers; 1994. pp. 372-380.
22. Mendall MA, Goggin PM, Molineaux N, et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992; 339:896-897.
23. EUROGAST Study Group. Epidemiology of, and risk factors for Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993; 34:1672-1676.
24. Sonnenberg A. Geographic and temporal variations in the occurrence of peptic ulcer disease. Scand J Gastroenterol 1985; 20(Suppl 110):11-24.
25. Sonnenberg A. The US temporal and geographic variations of diseases related to Helicobacter pylori. Am J Public Health 1993, 83:1006-1010.
26. Holcombe C. Helicobacter pylori: the African enigma. Gut 1992; 33:429-431.
27. Anand BS, Raed AK, Malaty HM, Genta RM, Klein PD, Evans DJ Jr, Graham DY. Low point prevalence of peptic ulcer in normal individuals with Helicobacter pylori infection. Am J Gastroenterol 1996; 91:1112-1115.
28. Ihamäki T, Varis K, Siurala M. Morphological, functional and immunological state of the gastric mucosa in gastric carcinoma families. Comparisons with a computer-matched family sample. Scand J Gastroenterol 1979; 14:801-812.
29. Katelaris PH, Tippett GHK, Norbu P, Lowe DG, Brennan R, Farthing MJG. Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India. Gut 1992; 33:1462-1466.
30. Khuroo MS, Majahan K, Zargar SA, Javid G, Munshi S. Prevalence of peptic ulcer in India: an endoscopic and epidemiological study in urban Kashmir. Gut 1989; 30:930-934.
31. Sipponen P, Varis K, Fräki O, Korri UM, Seppälä K, Siurala M. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. Scand J Gastroenterol 1990; 25:966-973.
32. Nomura A, Stemmermann GN, Chyou PH, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Int Med 1994; 120:977-981.
33. Cullen DJE, Collins J, Christiansen KJ, Epis J, Warren JR, Cullen KJ. Long-term risk of peptic ulcer disease in people with Helicobacter pylori infection - a community based study. (Abstract) Gastroenterology 1993; 104(Suppl):A60
34. Cervero F. Neurophysiology of gastrointestinal pain. Bailliere's Clin Gastroenterol 1988; 2:183-199.
35. Stead RH, Hewlett BR, Lhotak S, Colley ECC, Frendo M, Dixon MF. Do gastric mucosal nerves remodel in H. pylori gastritis? In Helicobacter pylori. Basic Mechanisms to Clinical Cure. Hunt RH, Tytgat GNJ (editors). Dordrecht, Boston, London: Kluwer Academic Publishers; 1994. pp. 281-291.
36. Grundy D. Speculations on the structure/function relationship for vagal and splanchnic afferent endings supplying the gastrointestinal tract. J Auton Nerv Syst 1988; 22:175-180.
37. Buckley M, O'Morain C. Helicobacter pylori and gastric cancer. Eur J Cancer Prevention 1995; 4:139-144.
38. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Int 1991; 41:45-60.